miRNA Market in America to Reach US$ 594 Million by 2018

‘The miRNA market in the Americas is likely to reach US$ 594 Million by 2018 growing at an impressive CAGR of around 22%’, says RNCOS.

 

Noida, UP -- (ReleaseWire) -- 06/12/2014 -- Currently, the Americas is the largest market in terms of miRNA based research. Within the Americas, the US is the chief geography wherein majority of the research associated with miRNA diagnostics/therapeutics application is being carried on. The miRNA market in the Americas is likely to reach US$ 594 Million by 2018. The respective market is anticipated to grow at an impressive CAGR of around 22% over the 6 year period spanning from 2012 to 2018.

The very growth can be attributed to the active research environment of the country, generous funding and support provided by the regulatory authorities, and high standards of research infrastructure and intellect. In the field of life sciences/genetics/biotechnology, one of the most zealously pursued research areas across the Americas (US) is miRNA. The application of miRNA is being widely tested in the domain of diagnostics and therapeutics, with diagnostics accounting for the major share. The key disease areas of focus in miRNA research, across the US, include Cancer, Leukemia, Hepatitis C, and Asthma.

The report, ā€œGlobal miRNA Market Outlook to 2018ā€, provides an in depth analysis of the various aspects of miRNA at the industry as well as the research front. It has been segmented into three sections i.e., the Americas, Europe and Asia Pacific. These sections have been studied in depth and various trends in terms of research and applicability have been identified. A brief overview of the primary diseases being studied in the core regions is also provided. After an exhaustive study of the industry, we have laid out the primary market players. Detailed product portfolio and recent developments of these players have been highlighted. Although majority of the players are working over a vast variety of products such as miRNA extraction and purification kits, miRNA mimics and inhibitors, there are other players who are solely providing miRNA associated diagnostic services and are assessing its therapeutic potential.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM649.htm

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

About RNCOS
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.